Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Irritable Bowel Syndrome, November 2022

Free Subscription


Abstracts

Retrieve all available abstracts of the following 89 articles:
HTML format


 

Single Articles

  1. ISHIOH M, Nozu T, Miyagishi S, Igarashi S, et al
    Activation of basal forebrain cholinergic neurons improves colonic hyperpermeability through the vagus nerve and adenosine A2B receptors in rats.
    Biochem Pharmacol. 2022;206:115331.
    PubMed    
    Abstract available

  2. MOAZZAM SW, Mobeen A, Siddiqui MA
    Efficacy of Jawarish Shahi a herbal formulation in irritable bowel syndrome: An open-labeled single-arm clinical trial.
    J Tradit Complement Med. 2022;12:529-535.
    PubMed    
    Abstract available

  3. DORFMAN L, El-Chammas K, Mansi S, Kaul A, et al
    Gastrocolonic Response.
    Curr Gastroenterol Rep. 2022 Nov 3. pii: 10.1007/s11894-022-00849.
    PubMed    
    Abstract available

  4. SCHOVSBO SU, Mollehave LT, Petersen MW, Ahrendt Bjerregaard A, et al
    Association between infections and functional somatic disorders: a cross-sectional population-based cohort study.
    BMJ Open. 2022;12:e066037.
    PubMed    
    Abstract available

  5. JACTEL SN, Olson JM, Wolin KY, Brown J, et al
    Efficacy of a Digital Personalized Elimination Diet for the Self-Management of Irritable Bowel Syndrome and Co-Morbid Irritable Bowel Syndrome and Inflammatory Bowel Disease.
    Clin Transl Gastroenterol. 2022 Nov 1. pii: 01720094-990000000-00105.
    PubMed    
    Abstract available

  6. WANG T, van Dijk L, Rijnaarts I, Hermes GDA, et al
    Methanogen Levels Are Significantly Associated with Fecal Microbiota Composition and Alpha Diversity in Healthy Adults and Irritable Bowel Syndrome Patients.
    Microbiol Spectr. 2022 Nov 2:e0165322. doi: 10.1128/spectrum.01653.
    PubMed    
    Abstract available

  7. KARAKAN T, Gundogdu A, Alagozlu H, Ekmen N, et al
    Artificial intelligence-based personalized diet: A pilot clinical study for irritable bowel syndrome.
    Gut Microbes. 2022;14:2138672.
    PubMed    
    Abstract available

  8. KITSELAAR WM, van der Vaart R, Perschl J, Numans ME, et al
    Predictors of Persistent Somatic Symptoms in the General Population: A systematic review of cohort studies.
    Psychosom Med. 2022 Oct 17. pii: 00006842-990000000-00071.
    PubMed    
    Abstract available

  9. SALARIEH N, Emami Meibodi A, Alipour S, Azimirad M, et al
    Characterization of the mucosal microbiota in patients with nodular lymphoid hyperplasia with concurrent irritable bowel syndrome compared to healthy controls.
    Mol Biol Rep. 2022 Oct 31. pii: 10.1007/s11033-022-07974.
    PubMed    
    Abstract available

  10. ALZABIBI MA, Shibani M, Alsuliman T, Ismail H, et al
    Fibromyalgia: epidemiology and risk factors, a population-based case-control study in Damascus, Syria.
    BMC Rheumatol. 2022;6:62.
    PubMed    
    Abstract available

  11. EETEMADI A, Tagkopoulos I
    Algorithmic lifestyle optimization.
    J Am Med Inform Assoc. 2022 Oct 29. pii: 6780144. doi: 10.1093.
    PubMed    
    Abstract available

  12. DAS DAD, Ghosh DS, Palanisamy DC, Guha DN, et al
    Efficacy of individualized homeopathic medicines in irritable bowel syndrome: A double-blind randomized, placebo-controlled trial.
    Explore (NY). 2022 Oct 19. pii: S1550-8307(22)00169.
    PubMed    
    Abstract available

  13. HU Y, Zhu M, Liu Y, Wang Z, et al
    Musical Meter Induces Interbrain Synchronization during Interpersonal Coordination.
    eNeuro. 2022;9.
    PubMed    
    Abstract available

  14. GEBALLA-KOUKOULA A, Gerssen A, Blokland MH, Nielen MWF, et al
    Immunoaffinity Plastic Blade Spray Mass Spectrometry for Rapid Confirmatory Analysis of Food Contaminants.
    J Am Soc Mass Spectrom. 2022;33:2038-2045.
    PubMed    
    Abstract available

  15. TRIPATHI G, Park M, Hossain M, Im SB, et al
    Fabrication and characterization of cellulose nano crystal and soya modified injectable brushite bone cement for enhanced bone regeneration.
    Int J Biol Macromol. 2022;221:1536-1544.
    PubMed    
    Abstract available

  16. ZHANG Y, Zhang J, Duan L
    The role of microbiota-mitochondria crosstalk in pathogenesis and therapy of intestinal diseases.
    Pharmacol Res. 2022;186:106530.
    PubMed    
    Abstract available

  17. FUJII R, Awaga Y, Nozawa K, Matsushita M, et al
    Regional brain activation during rectal distention and attenuation with alosetron in a nonhuman primate model of irritable bowel syndrome.
    FASEB Bioadv. 2022;4:694-708.
    PubMed    
    Abstract available

  18. MATSUSHIMA S, Kuromizu J, Miyajima N, Beniya A, et al
    Characteristics of Fecal Incontinence in Male Patients in Japan.
    J Anus Rectum Colon. 2022;6:274-281.
    PubMed    
    Abstract available

  19. BHATTACHARJEE S, Siyad I, Maramattom BV
    Chronic diarrhea - The poetic masquerade.
    J Postgrad Med. 2022;68:239-242.
    PubMed    
    Abstract available

  20. MOBASHERI F, Shidfar F, Aminianfar A, Keshteli AH, et al
    The association between dietary acid load and odds and severity of irritable bowel syndrome in adults.
    Sci Rep. 2022;12:18943.
    PubMed    
    Abstract available

  21. MELCHIOR C, Wilpart K, Midenfjord I, Trindade IA, et al
    Relationship Between Abuse History and Gastrointestinal and Extraintestinal Symptom Severity in Irritable Bowel Syndrome.
    Psychosom Med. 2022;84:1021-1033.
    PubMed    
    Abstract available

  22. TKACH S, Dorofeyev A, Kuzenko I, Sulaieva O, et al
    Fecal microbiota transplantation in patients with post-infectious irritable bowel syndrome: A randomized, clinical trial.
    Front Med (Lausanne). 2022;9:994911.
    PubMed    
    Abstract available

  23. GRASA L, Brzozowski T, Seelaender M
    Editorial: Emerging talents in Frontiers in pharmacology: Gastrointestinal and hepatic pharmacology 2022.
    Front Pharmacol. 2022;13:1055030.
    PubMed    


  24. CHANG L
    Dietary Concerns and Patient-Focused Care in Irritable Bowel Syndrome.
    Gastroenterol Hepatol (N Y). 2022;18:351-353.
    PubMed    


  25. TORRES-MARAVILLA E, Holowacz S, Delannoy J, Lenoir L, et al
    Serpin-positive Bifidobacterium breve CNCM I-5644 improves intestinal permeability in two models of irritable bowel syndrome.
    Sci Rep. 2022;12:19776.
    PubMed    
    Abstract available

  26. OH JE, Chey WD, Spiegel B
    Abdominal Bloating in the US: Results of a Survey of 88,795 Americans Examining Prevalence and Healthcare Seeking.
    Clin Gastroenterol Hepatol. 2022 Nov 4. pii: S1542-3565(22)01020.
    PubMed    
    Abstract available

  27. PILIPENKO VI, Isakov VA, Morozov SV, Vlasova AV, et al
    [Efficacy of newly developed kombucha-based specialized food product for treatment of constipation-predominant irritable bowel syndrome].
    Vopr Pitan. 2022;91:95-104.
    PubMed    
    Abstract available

  28. BOOTZ-MAOZ H, Pearl A, Melzer E, Malnick S, et al
    Diet-induced modifications to human microbiome reshape colonic homeostasis in irritable bowel syndrome.
    Cell Rep. 2022;41:111657.
    PubMed    
    Abstract available

  29. ALGERA JP, Demir D, Tornblom H, Nybacka S, et al
    Low FODMAP diet reduces gastrointestinal symptoms in irritable bowel syndrome and clinical response could be predicted by symptom severity: A randomized crossover trial.
    Clin Nutr. 2022;41:2792-2800.
    PubMed    
    Abstract available

  30. VAZQUEZ-FRIAS R, Consuelo-Sanchez A, Acosta-Rodriguez-Bueno CP, Blanco-Montero A, et al
    Efficacy and Safety of the Adjuvant Use of Probiotic Bacillus clausii Strains in Pediatric Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study.
    Paediatr Drugs. 2022 Nov 16. pii: 10.1007/s40272-022-00536.
    PubMed    
    Abstract available

  31. NAKAMURA Y, Suzuki S, Murakami S, Nishimoto Y, et al
    Integrated gut microbiome and metabolome analyses identified fecal biomarkers for bowel movement regulation by Bifidobacterium longum BB536 supplementation: A RCT.
    Comput Struct Biotechnol J. 2022;20:5847-5858.
    PubMed    
    Abstract available

  32. VALENCIA C, Fatima H, Nwankwo I, Anam M, et al
    A Correlation Between the Pathogenic Processes of Fibromyalgia and Irritable Bowel Syndrome in the Middle-Aged Population: A Systematic Review.
    Cureus. 2022;14:e29923.
    PubMed    
    Abstract available

  33. LI DJ, Chen MH, Bai YM, Tsai SJ, et al
    Parental post-traumatic stress disorder and increased risk of chronic pain conditions and major psychiatric disorders in their offspring.
    Gen Hosp Psychiatry. 2022;79:152-157.
    PubMed    
    Abstract available

  34. CHAOJU X, Zhangyin S, Changchun JI, Jinsheng Y, et al
    Efficacy and safety of blood pricking and cupping for treating nonspecific low back pain: a systematic review and Meta-analysis.
    J Tradit Chin Med. 2022;42:869-876.
    PubMed    
    Abstract available

  35. HENNINGSEN P, Hausteiner-Wiehle C, Hauser W
    Migraine in the context of chronic primary pain, chronic overlapping pain disorders, and functional somatic disorders: A narrative review.
    Headache. 2022 Nov 14. doi: 10.1111/head.14419.
    PubMed    
    Abstract available

  36. SU Q, Liu Q, Lau RI, Zhang J, et al
    Faecal microbiome-based machine learning for multi-class disease diagnosis.
    Nat Commun. 2022;13:6818.
    PubMed    
    Abstract available

  37. LIN M, Hu G, Yu B
    Dysregulated cystathionine-beta-synthase/hydrogen sulfide signaling promotes chronic stress-induced colonic hypermotility in rats.
    Neurogastroenterol Motil. 2022 Nov 13:e14488. doi: 10.1111/nmo.14488.
    PubMed    
    Abstract available

  38. NAIK TD, Tubaki BR, Patankar DS
    Efficacy of whole system ayurveda protocol in irritable bowel syndrome - A Randomized controlled clinical trial.
    J Ayurveda Integr Med. 2022 Nov 9:100592. doi: 10.1016/j.jaim.2022.100592.
    PubMed    
    Abstract available

  39. CAPONIO GR, Celano G, Calabrese FM, Riezzo G, et al
    Evaluation of the Effects of the Tritordeum-Based Diet Compared to the Low-FODMAPs Diet on the Fecal Metabolome of IBS-D Patients: A Preliminary Investigation.
    Nutrients. 2022;14.
    PubMed    
    Abstract available

  40. WIECEK M, Panufnik P, Kaniewska M, Lewandowski K, et al
    Low-FODMAP Diet for the Management of Irritable Bowel Syndrome in Remission of IBD.
    Nutrients. 2022;14.
    PubMed    
    Abstract available

  41. GASIOROWSKA A, Romanowski M, Walecka-Kapica E, Kaczka A, et al
    Effects of Microencapsulated Sodium Butyrate, Probiotics and Short Chain Fructooligosaccharides in Patients with Irritable Bowel Syndrome: A Study Protocol of a Randomized Double-Blind Placebo-Controlled Trial.
    J Clin Med. 2022;11.
    PubMed    
    Abstract available

  42. BABOS CI, Leucuta DC, Dumitrascu DL
    Meditation and Irritable Bowel Syndrome, a Systematic Review and Meta-Analysis.
    J Clin Med. 2022;11.
    PubMed    
    Abstract available

  43. STORR M, Weigmann H, Landes S, Michel MC, et al
    Self-Medication for the Treatment of Abdominal Cramps and Pain-A Real-Life Comparison of Three Frequently Used Preparations.
    J Clin Med. 2022;11.
    PubMed    
    Abstract available

  44. YANG YY, Jun S
    The Effects of Cognitive Behavioral Therapy for Insomnia among College Students with Irritable Bowel Syndrome: A Randomized Controlled Trial.
    Int J Environ Res Public Health. 2022;19.
    PubMed    
    Abstract available

  45. VARGA L, Edvine EM, Hudak P, Anton I, et al
    Balancing at the Borderline of a Breed: A Case Study of the Hungarian Short-Haired Vizsla Dog Breed, Definition of the Breed Profile Using Simple SNP-Based Methods.
    Genes (Basel). 2022;13.
    PubMed    
    Abstract available

  46. GALMICHE M, Godefroy C, Achamrah N, Grigioni S, et al
    Mental health and health behaviours among patients with eating disorders: a case-control study in France.
    J Eat Disord. 2022;10:160.
    PubMed    
    Abstract available

  47. VAN DER POST LFM, Wierdsma AI, Peen J, van Boeijen CA, et al
    [Differences in the prevalence of acute involuntary admissions between Apeldoorn, Rotterdam and Amsterdam].
    Tijdschr Psychiatr. 2022;64:580-587.
    PubMed    
    Abstract available

  48. YU J, Guo L, Zhang SH, Zhu QY, et al
    Transcriptomic analysis of intermuscular bone development in barbel steed (Hemibarbus labeo).
    Comp Biochem Physiol Part D Genomics Proteomics. 2022;44:101030.
    PubMed    
    Abstract available

  49. SONGTANIN B, Peterson CJ, Molehin AJ, Nugent K, et al
    Biofilms and Benign Colonic Diseases.
    Int J Mol Sci. 2022;23:14259.
    PubMed    
    Abstract available

  50. ESAWY MM, Saleh Al-Sowayan N, Mobasher MA, Abd-Elhameed A, et al
    H19 and TUG1 lncRNAs as Novel Biomarkers for Irritable Bowel Syndrome in Diabetic Patients.
    Biomedicines. 2022;10:2978.
    PubMed    
    Abstract available

  51. NOBLE H, Hasan SS, Simpson V, Whorwell PJ, et al
    Patient satisfaction after remotely delivered gut-directed hypnotherapy for irritable bowel syndrome during the COVID-19 era: implications for future practice.
    BMJ Open Gastroenterol. 2022;9:e001039.
    PubMed    
    Abstract available

  52. PESSARELLI T, Sorge A, Elli L, Costantino A, et al
    The low-FODMAP diet and the gluten-free diet in the management of functional abdominal bloating and distension.
    Front Nutr. 2022;9:1007716.
    PubMed    
    Abstract available

  53. FRIELING T, Gjini B, Melchior I, Euler P, et al
    Endoscopic laser endomicroscopy and "leaky gut" in patients with functional gastrointestinal symptoms and food intolerance.
    Z Gastroenterol. 2022 Nov 23. doi: 10.1055/a-1959-3200.
    PubMed    
    Abstract available

  54. WANG FY, Kang EY, Liu CH, Ng CY, et al
    Diabetic Patients With Rosacea Increase the Risks of Diabetic Macular Edema, Dry Eye Disease, Glaucoma, and Cataract.
    Asia Pac J Ophthalmol (Phila). 2022;11:505-513.
    PubMed    
    Abstract available

  55. FRITSCHE LG, Jin W, Admon AJ, Mukherjee B, et al
    Characterizing and Predicting Post-Acute Sequelae of SARS CoV-2 infection (PASC) in a Large Academic Medical Center in the US.
    medRxiv. 2022 Nov 17:2022.10.21.22281356. doi: 10.1101/2022.10.21.22281356.
    PubMed    
    Abstract available

  56. AZIZ AI, Nguyen LC, Oumeslakht L, Bensussan A, et al
    Cannabinoids as Immune System Modulators: Cannabidiol Potential Therapeutic Approaches and Limitations.
    Cannabis Cannabinoid Res. 2022 Nov 22. doi: 10.1089/can.2022.0133.
    PubMed    
    Abstract available

  57. MALIK ZI, Umer MF, Ali KN, Kawish AB, et al
    Functional Gastrointestinal Diseases and Dietary Practices among Pakistani Children-A Schools Based Cross-Sectional Study.
    Diseases. 2022;10:103.
    PubMed    
    Abstract available

  58. LIU F, Shen Y, Li J, Bi L, et al
    Characteristics of ginsenoside Rd-induced effects on rat intestinal contractility with irritable bowel syndrome.
    Nat Prod Res. 2022 Nov 22:1-6. doi: 10.1080/14786419.2022.2146686.
    PubMed    
    Abstract available

  59. MAHMOUDI H, Hossainpour H
    Application and development of fecal microbiota transplantation in the treatment of gastrointestinal and metabolic diseases: A review.
    Saudi J Gastroenterol. 2022 Nov 14. doi: 10.4103.
    PubMed    
    Abstract available

  60. SINGH N, Singh V, Rai SN, Mishra V, et al
    Deciphering the gut microbiome in neurodegenerative diseases and metagenomic approaches for characterization of gut microbes.
    Biomed Pharmacother. 2022;156:113958.
    PubMed    
    Abstract available

  61. PINGALI H, Hunter SD
    Exploring mechanisms of blood pressure regulation in response to device-guided and non-device-guided slow breathing: A mini review.
    Auton Neurosci. 2022;244:103050.
    PubMed    
    Abstract available

  62. HE X, Ji P, Guo R, Ming X, et al
    Regulation of the central amygdala on intestinal motility and behavior via the lateral hypothalamus in irritable bowel syndrome model mice.
    Neurogastroenterol Motil. 2022 Nov 21:e14498. doi: 10.1111/nmo.14498.
    PubMed    
    Abstract available

  63. LIU J, Lv C, Wang W, Huang Y, et al
    Slow, deep breathing intervention improved symptoms and altered rectal sensitivity in patients with constipation-predominant irritable bowel syndrome.
    Front Neurosci. 2022;16:1034547.
    PubMed    
    Abstract available

  64. SHIN C, Ali S, Hussain S, Trivedi I, et al
    Epidemiology of irritable bowel syndrome in hospitalized patients with inflammatory bowel disease: Nationwide Inpatient Sample analysis from 2007-2016.
    Ann Gastroenterol. 2022;35:603-608.
    PubMed    
    Abstract available

  65. ZHOU Y, Yang D, Gu W
    Efficacy and Mechanism of Trimebutine Maleate Combined with Lactulose in the Treatment of Constipation-Predominant Irritable Bowel Syndrome in the Elderly.
    Emerg Med Int. 2022;2022:6125120.
    PubMed    
    Abstract available

  66. LUO Y, Shah BJ, Keefer LA
    Special Considerations for the Management of Disorders of Gut-Brain Interaction in Older Adults.
    Curr Treat Options Gastroenterol. 2022.
    PubMed    
    Abstract available

  67. SAMUTHPONGTORN C, Kantagowit P, Pittayanon R, Patcharatrakul T, et al
    Fecal microbiota transplantation in irritable bowel syndrome: A meta-analysis of randomized controlled trials.
    Front Med (Lausanne). 2022;9:1039284.
    PubMed    
    Abstract available

  68. SANEIE S, Aminianfar A, Shidfar F, Keshteli AH, et al
    The association between dietary total antioxidant capacity and odds and severity of irritable bowel syndrome among Iranian adults: a cross-sectional study.
    BMC Gastroenterol. 2022;22:472.
    PubMed    
    Abstract available

  69. BENDAVID E, Pfaller CK, Pan Y, Samuel CE, et al
    Host 5'-3' Exoribonuclease XRN1 Acts as a Proviral Factor for Measles Virus Replication by Downregulating the dsRNA-Activated Kinase PKR.
    J Virol. 2022;96:e0131922.
    PubMed    
    Abstract available

  70. BUSCAJONI L, Martinetz MC, Berkemeyer M, Brocard C, et al
    Refolding in the modern biopharmaceutical industry.
    Biotechnol Adv. 2022;61:108050.
    PubMed    
    Abstract available

  71. KERN D, Ljotsson B, Lonndahl L, Hedman-Lagerlof E, et al
    Optimized User Experience, Efficiency, and Resource Use in Online Self-Management of Atopic Dermatitis.
    JAMA Dermatol. 2022;158:1325-1327.
    PubMed    


  72. LEMBO A, Kuo B, Boinpally R, Li E, et al
    Randomised clinical trial: effects of MD-7246 on irritable bowel syndrome with diarrhoea.
    Aliment Pharmacol Ther. 2022 Nov 2. doi: 10.1111/apt.17274.
    PubMed    
    Abstract available

  73. QUIGLEY EMM, Markinson L, Stevenson A, Treasure FP, et al
    Randomised clinical trial: efficacy and safety of the live biotherapeutic product MRx1234 in patients with irritable bowel syndrome.
    Aliment Pharmacol Ther. 2022 Nov 11. doi: 10.1111/apt.17310.
    PubMed    
    Abstract available

  74. FITZPATRICK JA, Halmos EP
    Editorial: gluten-free but not pain-free in IBS.
    Aliment Pharmacol Ther. 2022;56.
    PubMed    


  75. ALGERA JP, Magnusson MK, Ohman L, Storsrud S, et al
    Editorial: gluten-free but not pain-free in IBS-authors' reply.
    Aliment Pharmacol Ther. 2022;56.
    PubMed    


  76. D'SILVA A, Marshall DA, Vallance JK, Nasser Y, et al
    Meditation and Yoga for Irritable Bowel Syndrome: A Randomized Clinical Trial.
    Am J Gastroenterol. 2022 Nov 25. doi: 10.14309/ajg.0000000000002052.
    PubMed    
    Abstract available

  77. CALVET X
    Recommendations for pharmacologic management of IBS with constipation.
    Ann Intern Med. 2022 Nov 1. doi: 10.7326/J22-0086.
    PubMed    
    Abstract available

  78. CALVET X
    Recommendations for pharmacologic management of IBS with diarrhea.
    Ann Intern Med. 2022 Nov 1. doi: 10.7326/J22-0087.
    PubMed    
    Abstract available

  79. JAMES K, Patel M, Goldsmith K, Moss-Morris R, et al
    Transdiagnostic therapy for persistent physical symptoms: A mediation analysis of the PRINCE secondary trial.
    Behav Res Ther. 2022;159:104224.
    PubMed    
    Abstract available

  80. PIOVEZANI RAMOS G, Camilleri M
    Current and Future Therapeutic Options for Irritable Bowel Syndrome with Diarrhea and Functional Diarrhea.
    Dig Dis Sci. 2022 Nov 14. pii: 10.1007/s10620-022-07700.
    PubMed    
    Abstract available

  81. JAGIELSKI CH, Harer KN
    Working with Trauma in the Gastroenterology Setting.
    Gastroenterol Clin North Am. 2022;51:867-883.
    PubMed    
    Abstract available

  82. SALWEN-DEREMER JK, Sun M
    Management of Sleep and Fatigue in Gastrointestinal Patients.
    Gastroenterol Clin North Am. 2022;51:829-847.
    PubMed    
    Abstract available

  83. BEDELL A, Friedlander A
    Management of Sexual Dysfunction in Gastrointestinal Disorders.
    Gastroenterol Clin North Am. 2022;51:815-828.
    PubMed    
    Abstract available

  84. BURTON MURRAY H, Ljotsson B
    Future of Brain-Gut Behavior Therapies: Mediators and Moderators.
    Gastroenterol Clin North Am. 2022;51:723-739.
    PubMed    
    Abstract available

  85. KINSINGER SW
    Practical Approaches to Working with a Gastrointestinal Psychologist.
    Gastroenterol Clin North Am. 2022;51:711-721.
    PubMed    
    Abstract available

  86. ASHRAF MU, Akhouri D, Bhardwaj D, Siddiqui B, et al
    A Study to Evaluate the Effectiveness of "Mindfulness-Based Stress Reduction Therapy(MBSRT)" in Reducing Symptom Severity and Improving Quality of Life in Patients Suffering From Irritable Bowel Syndrome.
    J Clin Gastroenterol. 2022 Nov 15. pii: 00004836-990000000-00097.
    PubMed    
    Abstract available

  87. GWEE KA, Lee YY, Suzuki H, Ghoshal UC, et al
    Asia-Pacific Guidelines for Managing Functional Dyspepsia Overlapping with Other Gastrointestinal Symptoms.
    J Gastroenterol Hepatol. 2022 Nov 1. doi: 10.1111/jgh.16046.
    PubMed    
    Abstract available

  88. MAROTI D, Lumley MA, Schubiner H, Lilliengren P, et al
    Internet-based emotional awareness and expression therapy for somatic symptom disorder: A randomized controlled trial.
    J Psychosom Res. 2022;163:111068.
    PubMed    
    Abstract available

  89. HINSE M, Thronicke A, Berghofer A, Matthes H, et al
    New multimodal intervention to reduce irritable bowel syndrome (IBS) severity symptoms-Pilot study with a 12 month follow-up.
    PLoS One. 2022;17:e0277880.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;